Cancer cure? Russia commences human trials of revolutionary personalized cancer vaccine
Gamaleya National Research Center
of Epidemiology and Microbiology—the creators of the Sputnik V COVID-19 vaccine—announced this year that it will begin human clinical trials of the world's first personalized mRNA-based
melanoma vaccine
within the next few months.
Alexander Gintsburg, director of the Gamaleya Center, confirmed that this groundbreaking vaccine, tailored specifically to the genetic profile of individual patients' tumors, will start experimental administration as early as September-October 2025 in collaboration with leading
Russian oncology institutions
.
Explore courses from Top Institutes in
Please select course:
Select a Course Category
Cybersecurity
CXO
others
Public Policy
Healthcare
Digital Marketing
Degree
MBA
Artificial Intelligence
Others
PGDM
Data Science
Data Analytics
Product Management
MCA
Operations Management
Leadership
Design Thinking
Project Management
Finance
Management
healthcare
Technology
Data Science
Skills you'll gain:
Duration:
10 Months
MIT xPRO
CERT-MIT xPRO PGC in Cybersecurity
Starts on
undefined
Get Details
Q. What are
melanoma
cells
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
15 most beautiful women in the world
Topgentlemen.com
Undo
A. Melanoma cells come from melanocytes, the skin cells that give it color. When these cells grow too much and become cancerous, they cause melanoma, a dangerous kind of skin cancer that can spread fast if not treated early.
Q. What is mRNA, and how is it used in vaccines?
A. mRNA, or messenger RNA, is a molecule that carries genetic instructions from DNA to the cell's protein-making machinery. It acts like a messenger, conveying the code needed to build specific proteins that perform various functions in the body. In vaccines, mRNA teaches cells to produce a harmless piece of a virus or cancer antigen, triggering the immune system to respond and protect the body.
Live Events
This novel
cancer vaccine
is designed to train the immune system to recognize and attack melanoma cells by creating a bespoke mRNA blueprint derived from each patient's unique tumor mutations. The process involves sophisticated artificial intelligence algorithms that analyze the tumor's genetic data to produce a molecular template, which is then synthesized at Gamaleya's production facilities. This tailor-made mRNA encodes proteins that activate a targeted cytotoxic immune response, aiming not only to eradicate primary tumors but also to address metastatic cancer sites.
Gintsburg elaborated that the entire vaccine development cycle—from tumor sequencing to vaccine production—can be completed within about one week due to AI-assisted mathematical modeling and neural network computing. This rapid manufacture represents a significant leap compared to typical timelines in personalized cancer therapies.
Q. What is a personalized cancer vaccine?
A. Personalized cancer vaccine is a tailored immunotherapy designed to train the patient's immune system to recognize and attack their specific cancer cells. It uses information from the patient's tumor genetics to create a unique vaccine that targets tumor-specific mutations, differing from general vaccines.
The vaccine model was developed starting in mid-2022 and has already demonstrated promising efficacy in preclinical animal studies, showing the ability to suppress tumor growth and reduce metastasis.
The upcoming Phase I clinical trials will take place at two of Russia's foremost oncology centers: the
Hertsen Research Institute
and the N.N. Blokhin National Medical Research Center of Oncology in Moscow. Importantly, this tailored vaccine is part of a wider Russian initiative to advance cancer treatment across various difficult-to-treat types, including pancreatic, kidney, and non-small-cell lung cancers.
The Russian Ministry of Health classifies this vaccine development and approval under a new, specialized regulatory process recognizing its individualized nature, differing fundamentally from traditional drug registration. The state plans to provide this cancer vaccine free of charge to Russian citizens, with an estimated production cost of around 300,000 rubles (approx. USD 2,869) per dose covered by government funding.
According to health authorities, about 4 million Russians live with cancer, and approximately 625,000 new cancer cases are diagnosed annually, underlining the urgent need for innovative therapies. The vaccine's success could mark a pivotal moment in Russia's fight against cancer and elevate its personalized medicine program.
Unlike the COVID-19 mRNA vaccines designed to target a single viral antigen, this personalized cancer vaccine encodes multiple neoantigens specific to each patient's tumor, offering a multi-targeted immune approach.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
In a rare reversal, US NIH reinstates 891 cancelled grants, leaving research teams in disarray
US NIH reinstates 891 cancelled research grants after court ruling. (AI Image) In a major reversal, the US National Institutes of Health (NIH) has reinstated 891 biomedical research grants that had previously been cancelled. The move follows a federal court order issued by a judge in Boston, prompting the agency to restore funding to projects that had faced abrupt termination. The grants were initially suspended earlier in the year, affecting hundreds of researchers across the country. Many of these scientists had already enrolled participants, hired staff, or committed resources to long-term studies. The sudden reinstatement, while restoring financial support, has introduced new operational challenges for research teams. Researchers face staffing and operational hurdles One such researcher, Ethan Moitra of Brown University, was among the first to learn that his grant had been cancelled in early February. His study focused on how the Covid-19 pandemic impacted depression and anxiety levels, particularly within LGBTQ+ populations. At the time of cancellation, he had enrolled 240 participants. Although the grant was reinstated in the current month, the short timeline and loss of staffing have made it difficult to resume the study. Moitra noted that only five weeks of funding remain, and that the original team had since disbanded. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Lara Green Is Retiring - Her Final Jewelry Pieces Are 80% Off The Heritage Journal Read More Undo Across the country, similar situations have unfolded. Scientists affected by the initial cancellations had been forced to lay off staff, retract job offers, and pause or completely halt research activities. While the reinstatement has brought a temporary reprieve, many projects are struggling to regain momentum due to administrative and staffing breakdowns. Court order prompts NIH to act The reinstatement of the grants came after a court ruling in Boston, which ordered the NIH to reverse its prior decisions. The ruling affected 891 biomedical research grants, all of which are now back in effect. The NIH has not provided a full statement on the reason for the initial cancellations or the court's findings. Lingering effects on US research infrastructure Although the funding has been restored, the long-term impact on US research programmes remains uncertain. The disruption caused by the grant cancellations has affected ongoing data collection, team structures, and project timelines. Many researchers are now facing compressed schedules, with some left with only a few weeks of funding to complete their studies. The reinstated grants cover a wide range of biomedical topics and were part of ongoing federal research initiatives. The temporary loss of these projects has contributed to wider operational challenges within the US scientific community. TOI Education is on WhatsApp now. Follow us here . Ready to navigate global policies? Secure your overseas future. Get expert guidance now!
Time of India
an hour ago
- Time of India
‘They want a win in November': Trump administration schedules first ‘Golden Dome' test ahead of 2028 election -Here's what report said
The Pentagon has scheduled its first major test of President Donald Trump's space-based Golden Dome missile defence system just before the 2028 elections, CNN reported, citing sources. This ambitious schedule aims to demonstrate the feasibility of transforming President Trump's concept of a space-based protective shield for the entire United States. This scheduling aligns with Trump's May announcement to 'have it done in three years.' "Once fully constructed, the Golden Dome will be capable of intercepting missiles even if they are launched from other sides of the world," he said. A defence official informed CNN that while missile tests typically require extensive advance planning, the timing of this test in the fourth quarter of 2028 appears strategically placed. "They want a win to point to in November [2028],' the official told CNN and added, 'and DoD wants to avoid anything they perceive will slow them down.' The defence official revealed that the MDA plans to designate the test as FTI-X, where 'FTI' indicates Flight Test Integrated, encompassing the coordination of Golden Dome's various sensors and weapons systems against multiple targets. The three-year implementation presents significant challenges, considering the US has researched space-based missile interception for decades. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Average Cost To Rent A Private Jet May Surprise You (View Prices) Private Jet I Search Ads Learn More Undo The defence official highlighted technical complexities, particularly regarding the substantial number of satellites required for effective coverage of the continental United States. Space Force Gen. Michael Guetlein, appointed by Trump in May to oversee Golden Dome's development, addressed these challenges at a recent industry summit, focusing on the technical and economic feasibility of space-based interceptors at scale. Initial tests in 2028 may represent only the first phase, according to another source, emphasising the current focus on swift progress using existing systems to demonstrate the concept's viability for additional funding. The project's allocated budget of $25 billion, announced by Trump in May, is expected to expand significantly into hundreds of billions. Various companies are already testing relevant technologies, including Northrop Grumman's work on space-based interceptors. The Pentagon recently announced successful testing of a Lockheed Martin long-range radar system in Alaska, capable of tracking ballistic missiles from Russia and China, likely to be incorporated into Golden Dome. The industry awaits Guetlein's comprehensive system design plan. A memo signed by defence secretary Pete Hegseth outlined a 60-day deadline for initial architecture and 120 days for implementation planning. Concerns exist regarding the accelerated development approach and reduced oversight. The Office of the Director of Operational Test and Evaluation's role was diminished after announcing its involvement in Golden Dome testing oversight. Guetlein has been granted significant autonomy in contract allocation and technology procurement, reporting directly to Deputy Secretary Stephen Feinberg. The programme operates outside standard Pentagon oversight procedures for major weapons systems. Multiple companies, notably SpaceX, Anduril, and Palantir, are competing for involvement, having presented directly to Hegseth, who has expressed interest in their proposals.
Time of India
2 hours ago
- Time of India
37L govt school children to undergo health screening by Dec: Edu dept
Ranchi: The School Education and Literacy Department has made health check-ups mandatory for all students under the National Child Health Program (RBSK) to ensure early detection and management of health issues among school-going children. The department has issued detailed guidelines to all districts to ensure 100% coverage of students enrolled in govt schools across the state. A comprehensive framework has been established to facilitate the smooth rollout of the initiative. Under this, a team-based structure has been formed, where each health team is assigned a target to conduct health checkups of 1,200 children per quarter. A quarterly plan is already in place, and 23 health check-up camps are scheduled til September. A letter in this regard has been sent to all districts, said sources in the education department. A target of 37 lakh children is set for the full cycle of health check-ups across Jharkhand, covering two key phases: July to September and October to December. Tt is now compulsory for schools to record the height and weight of all students every six months using height and weight measuring machines available at every school. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Lara Green Is Retiring - Her Final Jewelry Pieces Are 80% Off The Heritage Journal Read More Undo Schools must maintain updated registers for monitoring child growth patterns and provide this data during the quarterly health visits. Each school will be supported by a coordinated effort involving the school principal, Bal Sansad (student parliament) members, cook-cum-helpers, the School Management Committee, Block Resource Persons (BRP), Cluster Resource Persons (CRP), Block Education Extension Officers (BEEO), and the District Education Superintendent (DES). The District Education Superintendent will coordinate with the Civil Surgeon to prepare and share a detailed quarterly visit plan to cover all schools under their jurisdiction. The Block Education Extension Officer will supervise the availability of Iron Folic Acid (IFA) and deworming tablets, ensuring that the expiry date of any distributed medicine is not less than six months. Special attention is given to single-teacher schools, where Block Resource Persons will support the lone educator in organising and managing the health camps. In the event of medicine shortages, BRPs are instructed to coordinate with the nearest Block Health Center to secure an adequate supply. The district-wise target for school children's health checkups during the ongoing quarter includes Giridih with the highest target of 5,47,569 children, followed by Palamu with 3,10,168, West Singhbhum/Chaibasa with 2,28,756, Sahebganj with 2,17,318, and Godda with 2,11,960. Other major districts include Ranchi with 2,00,691, Garhwa with 2,07,191, and Pakur with 1,57,687. Districts like Deoghar, Hazaribagh, Gumla, and East Singhbhum also have substantial targets, while smaller districts such as Simdega, Koderma, Ramgarh, Lohardaga, and Khunti have lower but focused targets to ensure every child is covered under the health initiative. Ranchi district superintendent of education Badal Raj said that they will soon issue directives to all schools in the district to begin testing in next few days. "Through this camp, the education department has reiterated the importance of inter-departmental coordination and community involvement to meet this mammoth health objective. Schools have taken the guidelines seriously and will contribute actively to the health and well-being of the student. " Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !
